StockData
RDYNYSEPharmaceutical PreparationsFiscal year ends March 31

DR REDDYS LABORATORIES LTD

Financials through fiscal 2025, year ended Mar 31, 2025
$13.08+0.01 (+0.08%)

Close on Oct 19, 2026

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
15.1%
126M of 835M shares
Institutional holders
238
31 new, 37 sold out
Net institutional buying
5M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Mr. G.V. Prasad : N/A21,762,60213.04%13D (active) amendmentMay 22, 2024
K. Satish Reddy113,356,51013.58%13D (active) amendmentSep 17, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of RDYValueChange% of portfolio
Robeco Institutional Asset Management B.V.18,021,1002.16%$261.13M+843,2180.32%
Morgan Stanley10,936,3201.31%$158.47M+1,564,7260.01%
BlackRock, Inc.10,585,7421.27%$153.39M−1,001,3850.00%
Royal Bank of Canada9,213,2691.10%$133.51M−770,8130.02%
Aikya Investment Management Ltd8,493,8521.02%$123.08M+494,05636.13%
Renaissance Technologies LLC7,347,0280.88%$106.46M−512,7000.15%
Dimensional Fund Advisors LP5,312,0650.64%$77.04M−11,1830.01%
State Street Corp4,124,6860.49%$59.77M+98,4790.00%
JPMorgan Chase & Co4,069,3570.49%$60.47M−302,0210.00%
Alliancebernstein L.P.3,730,7130.45%$51.67M+1,188,8240.02%
Vanguard Capital Management LLC3,100,9110.37%$44.93M–0.00%
Franklin Resources Inc2,844,5830.34%$41.22M−11,5110.01%
Nuveen, LLC2,827,6990.34%$40.97MNew0.01%
Bnp Paribas Arbitrage, Snc2,649,8660.32%$38.40M−534,1050.01%
Acadian Asset Management LLC2,260,2430.27%$32.74K−148,5180.04%
Marshall Wace, Llp2,025,3560.24%$29.35M−638,9500.02%
Bessemer Group Inc1,857,2210.22%$26.91K+33,9360.04%
American Century Companies Inc1,830,8830.22%$26.53M+169,5500.01%
UBS Group AG1,658,5360.20%$24.03M+106,2280.00%
Schroder Investment Management Group1,618,4040.19%$24.05M+1,437,1650.02%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026238126M15.1%31 / 7597 / 3713M8M
Q1 2026249120M14.4%41 / 10266 / 2625M6M
Q4 2025237107M12.8%41 / 8474 / 248M14M
Q3 2025228113M13.5%26 / 8576 / 3913M18M
Q2 2025243118M14.1%36 / 10860 / 3224M16M
Q1 2025246110M13.2%35 / 60115 / 339M18M
Q4 2024248119M14.2%37 / 2043 / 1795M0M
Q3 202422924M2.9%31 / 9758 / 213M2M
Q2 202422225M3.0%25 / 1196 / 310M103M
Q1 2024231128M15.4%29 / 9374 / 2018M12M
Q4 2023224122M14.6%38 / 8366 / 2524M11M
Q3 2023212109M13.1%33 / 8860 / 1418M12M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

FundShares% of RDYValue% of fundAs of
AB Emerging Markets Opportunities ETF3,717,2140.45%$53.86M2.54%Jun 30, 2026
College Retirement Equities Fund - Total Global Stock Account2,031,2810.24%$29.43M0.02%Jun 30, 2026
Vanguard Emerging Markets Stock Index Fund1,873,9800.22%$22.21M0.01%Jul 31, 2026
Avantis Emerging Markets Equity ETF1,715,8400.21%$23.39M0.09%May 31, 2026
State Street(R) SPDR(R) Portfolio Emerging Markets ETF1,462,4310.18%$21.19M0.12%Jun 30, 2026
Vanguard Global Minimum Volatility Fund1,369,3050.16%$16.23M0.81%Jul 31, 2026
Emerging Markets Core Equity 2 Portfolio1,350,1400.16%$16.00M0.04%Jul 31, 2026
Vanguard Total International Stock Index Fund874,0710.10%$10.36M0.00%Jul 31, 2026
Nuveen Emerging Markets Equity Fund739,0960.09%$8.76M0.49%Jul 31, 2026
The Emerging Markets Series511,8860.06%$6.07M0.07%Jul 31, 2026
Templeton Emerging Markets Equity Fund489,8090.06%$7.10M0.26%Jun 30, 2026
SIT Emerging Markets Equity Fund476,7020.06%$6.91M0.39%Jun 30, 2026
Dimensional Emerging Markets Value Fund420,8300.05%$4.99M0.03%Jul 31, 2026
Dimensional Emerging Core Equity Market ETF411,1830.05%$4.87M0.05%Jul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF371,9640.04%$4.41M0.05%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Madhu Sundar Subramanian MunnirpallamGlobal Head of Quality and PV35,6000.00%Apr 10, 2026
Deepak SapraCEO - API and Services75,6240.01%Apr 1, 2026
Sushrut KulkarniGLOBAL HEAD - IPDO700.00%Apr 1, 2026
Erez IsraeliCHIEF EXECUTIVE OFFICER––Apr 1, 2026
Venkata Ramana MotupalliCEO - Global Generics68,2300.01%Apr 1, 2026
Patrick Rudolf AghanianHead - Europe Generics8,4500.00%Apr 1, 2026
Milan Kantilal KalawadiaCEO - North America47,3250.01%Apr 1, 2026
Krishna VenkateshGlobal Head - IPDO––Apr 1, 2026
Venkata Narasimham MannamChief Financial Officer61,2450.01%Apr 1, 2026
Srinivasa Phanimitra BhethanabottlaChief Information Officer8,7120.00%Apr 1, 2026
Alpna SethDirector––Apr 1, 2026
Sanjiv Soshil MehtaDirector––Mar 27, 2026
Arun Madhavan KumarDirector––Mar 27, 2026
Pranatharthi Haran Krishnan KodumudiDirector––Mar 27, 2026
Penny Chan WanDirector––Mar 27, 2026
Leo PuriDirector––Mar 27, 2026
Shikha Sanjaya SharmaDirector––Mar 27, 2026
G. V. PrasadDirector108,813,01013.04%Mar 20, 2026
K. Satish ReddyDirector113,356,51013.58%Mar 20, 2026

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Erez Israeli
Officer, Director
Jul 29, 202465,500$5.39MJul 29, 2024SALARY/STOCK BONUS
Erez Israeli
Officer
Oct 27, 20235,000$327.25KOct 30, 2023EMPLOYMENT INCOME/STOCK BONUS
Erez Israeli
Officer, Director
Jul 27, 2023197,165$13.20MJul 29, 2023EMPLOYMENT INCOME/STOCK BONUS